Suppression of plasma 6-keto-prostaglandin F1 alpha and 13,14-dihydro-15-keto-prostaglandin F2 alpha by aminoglutethimide in advanced breast cancer.
D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood*; D000616:Aminoglutethimide / Q000494:pharmacology* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000097:blood* / Q000188:drug therapy; D015237:Dinoprost / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D011460:Prostaglandins F / Q000097:blood*
D011460:Prostaglandins F; D000616:Aminoglutethimide; C008228:15-keto-13,14-dihydroprostaglandin F2alpha; D015121:6-Ketoprostaglandin F1 alpha; D015237:Dinoprost